Study of INCA036978 in Participants With Myeloproliferative Neoplasms

Clinical trial NCT07441694 · RECRUITING

Trial details

NCT number: NCT07441694
Sponsor: Incyte Corporation
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Myeloproliferative Neoplasms

Start date: 2026-05-11
Primary completion: 2030-05-24
Enrollment: 218

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.